Pharmed has sold Accuscience to Diploma PLC
Ireland and UK-based Accuscience has been sold by Pharmed to Diploma PLC.
Accuscience, based in Naas, Ireland, distributes life sciences and medtech equipment. It is a recognized leader in core market segments of the Irish healthcare sector, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities. Through relationships with over 100 suppliers, it delivers a full continuum of value-add services in both Ireland and Northern Ireland, including to the HSE and the NHS.
Diploma is an international group supplying specialized products and services in the life sciences, seals and controls sectors across the UK, Northern Europe, North America and Australia.
Pharmed is a major healthcare and pharmaceutical services provider in Ireland and the UK offering a variety of tailor-made solutions to distribution, sales and marketing for the purpose of representing manufacturers of beauty, pharmaceutical and OTC products. With established global networks, Pharmed provides an extensive range of services to meet the strategic requirements of its partners.
Oaklins’ team in Ireland provided corporate finance advice to Pharmed in this sell-side transaction as well as overall project management services to management and the board. This was a very competitive process with a number of serious bidders from multiple jurisdictions in Europe.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more